Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility and Outcomes of Cytoreductive Surgery and Hyperthermic Intrathoracic Chemoperfusion for Pleural Mesothelioma.

The Annals of thoracic surgery·2026
Same author

Regional characteristics of esophageal cancer and robot-assisted minimally invasive esophagectomy (RAMIE): an analysis of the international UGIRA registry.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2026
Same author

ASO Visual Abstract: Outcome Analysis of Cytoreductive Surgery and Hyperthermic Intrathoracic Chemoperfusion (HITHOC) for Pseudomyxoma Peritonei with Pleural Metastasis.

Annals of surgical oncology·2026
Same author

ASO Author Reflections: When Evidence is Limited: How Surgical Teams Navigate Rare Pleural Disease.

Annals of surgical oncology·2025
Same author

Outcome Analysis of Cytoreductive Surgery and Hyperthermic Intrathoracic Chemoperfusion (HITHOC) for Pseudomyxoma Peritonei with Pleural Metastasis.

Annals of surgical oncology·2025
Same author

Consensus map for robotic right lower lobectomy-essential components for artificial intelligence and education applications.

Journal of thoracic disease·2025
Same journal

Coronary artery bypass grafting based on computed tomography-derived fractional flow reserve versus angiography: Early results.

The Annals of thoracic surgery·2026
Same journal

Beyond R0: Margin Cytology and Local Control After Sublobar Resection.

The Annals of thoracic surgery·2026
Same journal

Deferred AVR During CABG in Moderate Aortic Stenosis: Lower Index Risk or Deferred Cumulative Risk?

The Annals of thoracic surgery·2026
Same journal

The Renaissance of Transapical TAVR: From Competing Access Route to Enabling Platform for Hybrid Heart Therapy.

The Annals of thoracic surgery·2026
Same journal

A Moving Target: Interpreting Post-TAVI Reintervention in a Rapidly Evolving Era.

The Annals of thoracic surgery·2026
Same journal

False Lumen Remodeling Versus Intraluminal Graft Thrombosis: Distinct Phenomena After Frozen Elephant Trunk Repair.

The Annals of thoracic surgery·2026
See all related articles

Related Experiment Video

Updated: Nov 17, 2025

Subcostal Specimen Removal in Completely Portal Robotic Lobectomy
04:38

Subcostal Specimen Removal in Completely Portal Robotic Lobectomy

Published on: April 19, 2024

455

Activity-Based Cost Analysis of Robotic Anatomic Lung Resection During Program Implementation.

Garrett N Coyan1, Michael Lu1, Kristine M Ruppert2

  • 1Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

The Annals of Thoracic Surgery
|February 18, 2021
PubMed
Summary
This summary is machine-generated.

Robotic-assisted lung resection (RALS) offers comparable clinical outcomes to video-assisted thoracoscopic surgery (VATS) with potentially lower controllable costs. This approach can be cost-advantageous within existing minimally invasive programs.

More Related Videos

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy
04:10

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy

Published on: July 19, 2024

981
Surgical Robot-Assisted Transanal Specimen Extraction Radical Sigmoidectomy Without an Auxiliary Abdominal Incision
07:22

Surgical Robot-Assisted Transanal Specimen Extraction Radical Sigmoidectomy Without an Auxiliary Abdominal Incision

Published on: June 13, 2025

367

Related Experiment Videos

Last Updated: Nov 17, 2025

Subcostal Specimen Removal in Completely Portal Robotic Lobectomy
04:38

Subcostal Specimen Removal in Completely Portal Robotic Lobectomy

Published on: April 19, 2024

455
Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy
04:10

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy

Published on: July 19, 2024

981
Surgical Robot-Assisted Transanal Specimen Extraction Radical Sigmoidectomy Without an Auxiliary Abdominal Incision
07:22

Surgical Robot-Assisted Transanal Specimen Extraction Radical Sigmoidectomy Without an Auxiliary Abdominal Incision

Published on: June 13, 2025

367

Area of Science:

  • Thoracic Surgery
  • Minimally Invasive Surgery
  • Robotic Surgery

Background:

  • Robotic-assisted lung resection adoption is increasing, but concerns about initial outcomes and costs persist.
  • This study evaluates the initial outcomes and cost-effectiveness of a newly established robotic lung resection program.

Purpose of the Study:

  • To compare perioperative and 30-day outcomes between robotic-assisted lobectomy/segmentectomy (RALS) and video-assisted thoracoscopic lobectomy/segmentectomy (VATS).
  • To conduct a detailed cost analysis of RALS versus VATS, including direct and indirect controllable costs.

Main Methods:

  • Retrospective review of patients undergoing RALS or VATS between August 2014 and January 2017.
  • 1:1 propensity matching based on preoperative characteristics.
  • Activity-based costing analysis of individual patient encounters.

Main Results:

  • No significant difference in 30-day mortality between RALS and VATS groups (0% vs 1.4%).
  • RALS demonstrated a decreased median length of stay (4 vs 7 days) and chest tube duration (3 vs 5 days).
  • Overall median controllable costs were significantly lower for RALS ($16,352) compared to VATS ($21,154).

Conclusions:

  • A robotic-assisted pulmonary resection program can be cost-advantageous while maintaining good clinical outcomes compared to VATS.
  • Process-of-care changes in RALS may contribute to reduced costs in this setting.